The effect of lersivirine on the pharmacokinetics of oral contraceptives
Latest Information Update: 18 Jun 2012
Price :
$35 *
At a glance
- Drugs Lersivirine (Primary) ; Ethinylestradiol/levonorgestrel
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Pfizer Global Research and Development
- 18 Jun 2012 New trial record
- 22 Apr 2012 Results published in the European Journal of Clinical Pharmacology.